Article
Adenoviral vectors for cardiovascular gene therapy applications: a clinical and industry perspective
24 May 2022
Abstract excerpt
Despite the development of novel pharmacological treatments, cardiovascular disease morbidity and mortality remain high indicating an unmet clinical need. Viral gene therapy enables targeted delivery of therapeutic transgenes and represents an attractive platform for tackling acquired and inherited cardiovascular diseases in the future. Current cardiovascular gene therapy trials in humans mainly focus on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
